Clinical trial
Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of…
NCT00124683 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00124683 |
|---|---|
| Title | Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1 |
| Official title | Optimizing Treatment for Schizophrenic Smokers |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Tobacco Use Cessation, Tobacco Use Disorder, Schizophrenia |
| Intervention type | Drug |
| Interventions | Bupropion, nicotine transdermal patch |
| Enrollment | 59 |
| Start date | Sep 1, 2001 |
| Completion | May 1, 2007 |
| First posted | Jul 28, 2005 |
| Last update posted | Jan 12, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: